Brumm Joshua T's Form 4 filing

Dyne Therapeutics, Inc. (DYN) · filed Sep 22, 2021

Accession no.: 0001209191-21-057324
Filed: Sep 22, 2021
Trade date: Sep 20-21, 2021
Filing delay: 2 days
Rule 10b5-1 plan: Not on the form (before 2023)

Original on SEC EDGAR (opens in a new tab)

This filing lists 2 non-derivative transactions. Open-market sales total $127.3K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
Owner	Relationship to the company
Brumm Joshua TCIK 0001528826	Director, Officer (See Remarks)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade date	Security	Transaction	Shares	Price	Value	Shares after	Ownership	Flags
Sep 20, 2021	Common Stock	SSaleDisposed	−3,425	$15.61^F2	−$53,464.25	103,602	Direct
Sep 21, 2021	Common Stock	SSaleDisposed	−4,584	$16.11^F4	−$73,848.24	99,018	Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

The price reported in Column 4 is a weighted average price that represents the price of all shares sold by a broker on September 20, 2021 on behalf of a group of employees of the issuer to satisfy tax withholding obligations. These shares were sold in multiple transactions at prices within the range of $15.22 to $16.01, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in footnote (2) and (4) of this Form 4.

Referenced by the price of 1 transaction in Table I.

The price reported in Column 4 is a weighted average price that represents the price of all shares sold by a broker on September 21, 2021 on behalf of a group of employees of the issuer to satisfy tax withholding obligations. These shares were sold in multiple transactions at prices within the range of $15.87 to $16.36, inclusive.

Referenced by the price of 1 transaction in Table I.

Remarks

Chief Executive Officer and President

Read the full filing on SEC EDGAR (opens in a new tab)